Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperoxaluria, Primary | 3 | 2024 | 25 | 1.920 |
Why?
|
Cystinuria | 3 | 2020 | 19 | 1.020 |
Why?
|
Hyperoxaluria | 2 | 2022 | 33 | 0.990 |
Why?
|
Spinal Dysraphism | 7 | 2022 | 178 | 0.880 |
Why?
|
Nephrolithiasis | 6 | 2024 | 117 | 0.860 |
Why?
|
Urinary Tract | 4 | 2021 | 305 | 0.830 |
Why?
|
Kidney Tubules, Collecting | 5 | 2017 | 163 | 0.610 |
Why?
|
Urologic Diseases | 1 | 2019 | 247 | 0.540 |
Why?
|
Renal Replacement Therapy | 8 | 2012 | 283 | 0.540 |
Why?
|
Sodium | 2 | 2011 | 1594 | 0.530 |
Why?
|
Glomerulosclerosis, Focal Segmental | 3 | 2004 | 336 | 0.490 |
Why?
|
Urinary Bladder, Neurogenic | 3 | 2021 | 176 | 0.440 |
Why?
|
Urogenital Abnormalities | 3 | 2021 | 255 | 0.430 |
Why?
|
Kidney Cortex | 1 | 2011 | 168 | 0.390 |
Why?
|
Nephrocalcinosis | 3 | 2017 | 51 | 0.390 |
Why?
|
Kidney Transplantation | 7 | 2024 | 4300 | 0.380 |
Why?
|
Meningomyelocele | 2 | 2021 | 182 | 0.320 |
Why?
|
Urolithiasis | 2 | 2022 | 125 | 0.300 |
Why?
|
Oxalates | 3 | 2022 | 99 | 0.290 |
Why?
|
Kidney Calculi | 2 | 2022 | 469 | 0.270 |
Why?
|
Denys-Drash Syndrome | 1 | 2005 | 7 | 0.250 |
Why?
|
Diarrhea | 1 | 2011 | 1320 | 0.240 |
Why?
|
Aquaporins | 3 | 2003 | 176 | 0.240 |
Why?
|
Wilms Tumor | 1 | 2005 | 379 | 0.200 |
Why?
|
Receptors, Purinergic P2 | 1 | 2022 | 152 | 0.190 |
Why?
|
Infant | 21 | 2021 | 36510 | 0.190 |
Why?
|
Graft Survival | 5 | 2019 | 3900 | 0.180 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4775 | 0.180 |
Why?
|
Renal Dialysis | 4 | 2024 | 1802 | 0.170 |
Why?
|
Kidney Function Tests | 2 | 2020 | 681 | 0.170 |
Why?
|
Living Donors | 2 | 2002 | 651 | 0.170 |
Why?
|
Kidney | 6 | 2021 | 7064 | 0.170 |
Why?
|
Acidosis, Renal Tubular | 1 | 2019 | 50 | 0.170 |
Why?
|
Early Diagnosis | 1 | 2024 | 1195 | 0.160 |
Why?
|
Child | 27 | 2022 | 80891 | 0.160 |
Why?
|
Pedigree | 4 | 2020 | 4544 | 0.160 |
Why?
|
Cations, Divalent | 1 | 1998 | 167 | 0.150 |
Why?
|
Vesico-Ureteral Reflux | 2 | 2021 | 433 | 0.150 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2019 | 195 | 0.150 |
Why?
|
Body Water | 1 | 1998 | 340 | 0.140 |
Why?
|
Minerals | 1 | 1998 | 282 | 0.140 |
Why?
|
Hypertension, Renovascular | 1 | 1997 | 115 | 0.140 |
Why?
|
RNA Interference | 2 | 2022 | 2836 | 0.140 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.130 |
Why?
|
Child, Preschool | 20 | 2022 | 42650 | 0.130 |
Why?
|
Forkhead Transcription Factors | 2 | 2020 | 1623 | 0.130 |
Why?
|
Infant, Newborn | 13 | 2021 | 26411 | 0.130 |
Why?
|
Antibiotic Prophylaxis | 1 | 2021 | 640 | 0.130 |
Why?
|
Anion Transport Proteins | 1 | 2016 | 141 | 0.130 |
Why?
|
Marfan Syndrome | 1 | 1997 | 237 | 0.120 |
Why?
|
Dietary Proteins | 2 | 2011 | 960 | 0.120 |
Why?
|
Mutation | 6 | 2020 | 30228 | 0.120 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 806 | 0.120 |
Why?
|
Neurofibromatoses | 1 | 2018 | 300 | 0.110 |
Why?
|
Nephrotic Syndrome | 1 | 2017 | 382 | 0.110 |
Why?
|
Humans | 46 | 2024 | 768393 | 0.110 |
Why?
|
Ion Channels | 1 | 1998 | 1044 | 0.110 |
Why?
|
Adolescent | 19 | 2020 | 89184 | 0.110 |
Why?
|
Urologic Surgical Procedures | 1 | 2015 | 299 | 0.100 |
Why?
|
Epithelium | 1 | 2017 | 1609 | 0.100 |
Why?
|
Tumor Lysis Syndrome | 1 | 2012 | 38 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2024 | 2400 | 0.100 |
Why?
|
Amiloride | 1 | 2011 | 116 | 0.100 |
Why?
|
Diet, Protein-Restricted | 1 | 2011 | 73 | 0.090 |
Why?
|
Microvilli | 1 | 2011 | 235 | 0.090 |
Why?
|
Male | 30 | 2022 | 364902 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2016 | 1445 | 0.090 |
Why?
|
Female | 27 | 2022 | 397089 | 0.090 |
Why?
|
Metabolism, Inborn Errors | 1 | 2012 | 290 | 0.090 |
Why?
|
Kidney Medulla | 2 | 2001 | 169 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2986 | 0.080 |
Why?
|
Population Surveillance | 1 | 2020 | 2598 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 18048 | 0.080 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2009 | 110 | 0.080 |
Why?
|
Urodynamics | 2 | 2021 | 348 | 0.080 |
Why?
|
Diuretics | 1 | 2011 | 612 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 5 | 2011 | 8199 | 0.080 |
Why?
|
Kidney Diseases | 2 | 2012 | 2103 | 0.080 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2011 | 394 | 0.080 |
Why?
|
Kidney Neoplasms | 1 | 2005 | 4303 | 0.080 |
Why?
|
Double-Blind Method | 1 | 2022 | 12456 | 0.070 |
Why?
|
Graft Rejection | 4 | 2019 | 4505 | 0.070 |
Why?
|
Biological Transport | 1 | 2011 | 2085 | 0.070 |
Why?
|
Nutritional Support | 1 | 2008 | 178 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1998 | 3612 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3827 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2011 | 2488 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8731 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2019 | 65379 | 0.070 |
Why?
|
Aldosterone | 1 | 2011 | 881 | 0.070 |
Why?
|
Registries | 6 | 2020 | 8379 | 0.070 |
Why?
|
Fetal Development | 1 | 2011 | 771 | 0.070 |
Why?
|
Aquaporin 6 | 3 | 2003 | 44 | 0.070 |
Why?
|
Recurrence | 3 | 2004 | 8506 | 0.060 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2034 | 0.060 |
Why?
|
Citric Acid | 1 | 2005 | 124 | 0.060 |
Why?
|
Aquaporin 2 | 3 | 2003 | 125 | 0.060 |
Why?
|
DNA Mutational Analysis | 3 | 2019 | 4120 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2296 | 0.060 |
Why?
|
Dogfish | 1 | 2003 | 11 | 0.060 |
Why?
|
Molecular Sequence Data | 2 | 2011 | 17626 | 0.050 |
Why?
|
Prospective Studies | 7 | 2021 | 54920 | 0.050 |
Why?
|
Dihydrotachysterol | 1 | 2003 | 4 | 0.050 |
Why?
|
Rats | 5 | 2011 | 23835 | 0.050 |
Why?
|
Algorithms | 1 | 2024 | 14154 | 0.050 |
Why?
|
Membranes, Artificial | 1 | 2005 | 367 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9614 | 0.050 |
Why?
|
Animals | 12 | 2022 | 169337 | 0.050 |
Why?
|
Calpain | 1 | 2003 | 147 | 0.050 |
Why?
|
Calcium Oxalate | 1 | 2022 | 75 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7453 | 0.050 |
Why?
|
Multiple Organ Failure | 1 | 2005 | 387 | 0.050 |
Why?
|
Adult | 12 | 2021 | 223640 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2491 | 0.050 |
Why?
|
Calcium-Binding Proteins | 2 | 2003 | 1084 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3804 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3541 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 60049 | 0.050 |
Why?
|
Energy Intake | 1 | 2008 | 2145 | 0.050 |
Why?
|
Amphibian Proteins | 1 | 2020 | 35 | 0.040 |
Why?
|
Transcription Factors | 1 | 2020 | 12166 | 0.040 |
Why?
|
Calcineurin | 1 | 2001 | 236 | 0.040 |
Why?
|
beta Carotene | 1 | 2022 | 523 | 0.040 |
Why?
|
Base Sequence | 1 | 2011 | 12422 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3048 | 0.040 |
Why?
|
Hostility | 1 | 2021 | 185 | 0.040 |
Why?
|
Cystine | 1 | 2020 | 93 | 0.040 |
Why?
|
Mutation, Missense | 2 | 2022 | 2593 | 0.040 |
Why?
|
Chloride-Bicarbonate Antiporters | 1 | 2019 | 103 | 0.040 |
Why?
|
Magnesium | 1 | 2003 | 816 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 1602 | 0.040 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 1 | 2019 | 150 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 484 | 0.040 |
Why?
|
Prognosis | 4 | 2019 | 30022 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2011 | 2537 | 0.040 |
Why?
|
Calcium, Dietary | 1 | 2022 | 533 | 0.040 |
Why?
|
Mice | 5 | 2022 | 82017 | 0.040 |
Why?
|
Calcium | 3 | 2022 | 5794 | 0.040 |
Why?
|
Aquaporin 3 | 1 | 1998 | 15 | 0.040 |
Why?
|
Larva | 1 | 2020 | 514 | 0.040 |
Why?
|
Arginine Vasopressin | 1 | 1998 | 125 | 0.040 |
Why?
|
Xenopus | 1 | 2020 | 710 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2018 | 2742 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2000 | 692 | 0.040 |
Why?
|
Receptors, Vasopressin | 1 | 1998 | 106 | 0.040 |
Why?
|
Immunoblotting | 2 | 2016 | 1647 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8615 | 0.040 |
Why?
|
Potassium | 1 | 2022 | 1318 | 0.040 |
Why?
|
Heparin | 1 | 2005 | 1636 | 0.040 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2017 | 83 | 0.040 |
Why?
|
Embryonic and Fetal Development | 1 | 1998 | 420 | 0.040 |
Why?
|
Heredity | 1 | 2017 | 149 | 0.030 |
Why?
|
Homeostasis | 2 | 2017 | 3349 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 1998 | 574 | 0.030 |
Why?
|
Vasopressins | 1 | 1998 | 358 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2011 | 12805 | 0.030 |
Why?
|
Acute Kidney Injury | 1 | 2008 | 1943 | 0.030 |
Why?
|
Cohort Studies | 5 | 2019 | 41795 | 0.030 |
Why?
|
Urea | 1 | 1998 | 446 | 0.030 |
Why?
|
Ribonuclease III | 1 | 2017 | 270 | 0.030 |
Why?
|
Phenotype | 3 | 2018 | 16721 | 0.030 |
Why?
|
Ureter | 1 | 1998 | 370 | 0.030 |
Why?
|
Kidney Tubules, Proximal | 1 | 2017 | 385 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13423 | 0.030 |
Why?
|
Hypercalcemia | 1 | 1998 | 423 | 0.030 |
Why?
|
Bicarbonates | 1 | 2016 | 292 | 0.030 |
Why?
|
Sulfates | 1 | 2016 | 379 | 0.030 |
Why?
|
Aorta, Abdominal | 1 | 2018 | 627 | 0.030 |
Why?
|
Down-Regulation | 2 | 2017 | 2940 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2017 | 384 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3666 | 0.030 |
Why?
|
Urography | 1 | 2015 | 316 | 0.030 |
Why?
|
Ureteroscopy | 1 | 2015 | 150 | 0.030 |
Why?
|
Endosomes | 3 | 2003 | 525 | 0.030 |
Why?
|
Ultrasonography | 2 | 2017 | 6001 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2008 | 15881 | 0.030 |
Why?
|
Heterozygote | 1 | 2020 | 2791 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14481 | 0.030 |
Why?
|
Urinary Bladder | 1 | 2020 | 1162 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 22296 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2281 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10117 | 0.030 |
Why?
|
Glycosylation | 1 | 2016 | 1100 | 0.030 |
Why?
|
Hemodialysis Solutions | 1 | 2012 | 7 | 0.030 |
Why?
|
Risk Factors | 4 | 2022 | 74962 | 0.030 |
Why?
|
Animals, Newborn | 1 | 1998 | 2695 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 755 | 0.030 |
Why?
|
Protein Folding | 1 | 2016 | 872 | 0.020 |
Why?
|
Protein Binding | 2 | 2020 | 9343 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 2750 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1207 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2475 | 0.020 |
Why?
|
Water | 1 | 1998 | 1418 | 0.020 |
Why?
|
Epitopes | 1 | 1998 | 2525 | 0.020 |
Why?
|
Syndrome | 1 | 2018 | 3275 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21544 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2604 | 0.020 |
Why?
|
Survival Rate | 3 | 2014 | 12870 | 0.020 |
Why?
|
United States | 5 | 2020 | 73150 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 13020 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6892 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3345 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1958 | 0.020 |
Why?
|
Fibrosis | 1 | 2017 | 2077 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2020 | 81801 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3212 | 0.020 |
Why?
|
Antibodies | 1 | 1998 | 2425 | 0.020 |
Why?
|
Pregnancy | 1 | 2011 | 30200 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2002 | 4209 | 0.020 |
Why?
|
Family | 1 | 2020 | 3208 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2019 | 1876 | 0.020 |
Why?
|
Anticoagulants | 1 | 2005 | 4843 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1998 | 2819 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1883 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2000 | 4427 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 4936 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 3955 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1642 | 0.020 |
Why?
|
Hemofiltration | 1 | 2008 | 59 | 0.020 |
Why?
|
Age Factors | 1 | 2004 | 18471 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 24318 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2931 | 0.020 |
Why?
|
Critical Illness | 2 | 2009 | 2755 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9371 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3587 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7598 | 0.010 |
Why?
|
Diet | 1 | 2022 | 8090 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20765 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15597 | 0.010 |
Why?
|
Leupeptins | 1 | 2003 | 113 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14737 | 0.010 |
Why?
|
Immune Sera | 1 | 2003 | 605 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 13042 | 0.010 |
Why?
|
Caseins | 1 | 2003 | 105 | 0.010 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2003 | 185 | 0.010 |
Why?
|
Trypsin | 1 | 2003 | 491 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18362 | 0.010 |
Why?
|
Demography | 1 | 2007 | 1642 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2001 | 10 | 0.010 |
Why?
|
Nephrons | 1 | 2003 | 168 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 2001 | 174 | 0.010 |
Why?
|
Graft Occlusion, Vascular | 1 | 2005 | 538 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2003 | 5900 | 0.010 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2008 | 1024 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2003 | 1065 | 0.010 |
Why?
|
Dextrans | 1 | 2003 | 574 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15455 | 0.010 |
Why?
|
Autoradiography | 1 | 2001 | 732 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15939 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13646 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9682 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2008 | 6241 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39407 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2003 | 11120 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1731 | 0.010 |
Why?
|
Aging | 1 | 1998 | 8764 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8075 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15872 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5878 | 0.010 |
Why?
|
Signal Transduction | 1 | 2001 | 23631 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2001 | 1753 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20224 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2001 | 1207 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2009 | 12092 | 0.010 |
Why?
|
Hemorrhage | 1 | 2005 | 3461 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2000 | 4834 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10776 | 0.010 |
Why?
|
Phosphorylation | 1 | 2001 | 8326 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 1998 | 2226 | 0.010 |
Why?
|
Chronic Disease | 1 | 2000 | 9379 | 0.000 |
Why?
|
Middle Aged | 1 | 2014 | 223491 | 0.000 |
Why?
|